OnLume Closes $7M Series A
OnLume Surgical announced recently that it has closed a $7 million Series A financing round. “The completion of the Series A financing, plus the Phase II grant from NCI, provides the…
Category Archives: Biotech
HealthMyne’s Radiomic Technology is Validated
HealthMyne’s technology as a radiomics tool to inform clinical decision-making, identify imaging biomarkers and predict tumor response to cancer treatment was validated by Cancer Control, the company announced recently. “By extracting…
SHINE, Phoenix Merge
SHINE Medical Technologies and Phoenix have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE, the companies announced today. “SHINE and Phoenix have shared a…
Promega Opens New R&D Facility
Promega has opened the Kornberg Center, its newly constructed research and development facility, the company announced today. According to a release, the three-story, 280,000-square-foot building will support core product and technology…
Stem Pharm Awarded $1.7M Grant
Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH), the company announced recently. According…
SHINE Announces Weathertight Facility, Board Members
SHINE Medical Technologies has completed exterior construction of its medical isotope production facility and made it weathertight for protection, the company announced today. According to a release, the facility can withstand…
BioForward, BIOQuebec to Formalize Relationship
BioForward and BIOQuebec, Quebec’s largest biosciences network, will sign a memorandum of understanding to form a cooperative relationship, the organizations announced recently. “This step will take us both a long…
HealthMyne Solution Receives Scientific Validation
HealthMyne’s radiomic and quantitative imaging solution was used in a lung carcinoma study that was published in Cancer Control, the company announced recently. According to a release, the study demonstrated HealthMyne’s…
Cellectar’s PLE Granted Japanese Patent
Cellectar Biosciences has received another patent by the Japanese Patent Office, this time for its proprietary phospholipid-ether (PLE), the company announced today. According to a release, the patent provides composition…
NorthStar, IBA Expand Collaboration
NorthStar Medical Radioisotopes and Ion Beam Applications (IBA), a provider of proton therapy solutions for the treatment of cancer, expanded its collaboration to increase the global availability of technetium-99m (Tc-99m),…
